Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy D Blakely

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2008
Anomalous dopamine release associated with a human dopamine transporter coding variantMichelle S Mazei-Robison, Erica Bowton, Marion Holy, et al.
Molecular Pharmacology|December 4, 2003
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout miceLaura A Volpicelli-Daley, Anna Hrabovska, Ellen G Duysen, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Optical Imaging Reveals Liver Metabolic Perturbations in Mblac1 Knockout MiceBusenur Ceyhan, Jacob LaMar, Parisa Nategh, et al.
The International Journal of Neuropsychopharmacology|January 7, 2011
Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortexSusan L Erickson, Anjalika R Gandhi, Josephine K Asafu-Adjei, et al.
BMC Neuroscience|June 24, 2009
Subcellular localization of the antidepressant-sensitive norepinephrine transporterHeinrich J G Matthies, Qiao Han, Angela Shields, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dotsIan D Tomlinson, Michael R Warnerment, John N Mason, et al.
Neurochemistry International|December 17, 2013
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorderMarc A Mergy, Raajaram Gowrishankar, Gwynne L Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2007
Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporterJohn N Mason, Darlene C Deecher, Rhonda L Richmond, et al.
Plos One|May 15, 2019
Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1Sarah B Robinson, Osama Refai, J Andrew Hardaway, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 31, 2003
Vesicular localization and activity-dependent trafficking of presynaptic choline transportersShawn M Ferguson, Valentina Savchenko, Subbu Apparsundaram, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2008
Anomalous dopamine release associated with a human dopamine transporter coding variantMichelle S Mazei-Robison, Erica Bowton, Marion Holy, et al.
Molecular Pharmacology|December 4, 2003
Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout miceLaura A Volpicelli-Daley, Anna Hrabovska, Ellen G Duysen, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 12, 2023
Optical Imaging Reveals Liver Metabolic Perturbations in Mblac1 Knockout MiceBusenur Ceyhan, Jacob LaMar, Parisa Nategh, et al.
The International Journal of Neuropsychopharmacology|January 7, 2011
Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortexSusan L Erickson, Anjalika R Gandhi, Josephine K Asafu-Adjei, et al.
BMC Neuroscience|June 24, 2009
Subcellular localization of the antidepressant-sensitive norepinephrine transporterHeinrich J G Matthies, Qiao Han, Angela Shields, et al.
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Synthesis and characterization of a pegylated derivative of 3-(1,2,3,6-tetrahydro-pyridin-4yl)-1H-indole (IDT199): a high affinity SERT ligand for conjugation to quantum dotsIan D Tomlinson, Michael R Warnerment, John N Mason, et al.
Neurochemistry International|December 17, 2013
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorderMarc A Mergy, Raajaram Gowrishankar, Gwynne L Davis, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2007
Desvenlafaxine succinate identifies novel antagonist binding determinants in the human norepinephrine transporterJohn N Mason, Darlene C Deecher, Rhonda L Richmond, et al.
Plos One|May 15, 2019
Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1Sarah B Robinson, Osama Refai, J Andrew Hardaway, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 31, 2003
Vesicular localization and activity-dependent trafficking of presynaptic choline transportersShawn M Ferguson, Valentina Savchenko, Subbu Apparsundaram, et al.
Pageof 23